The Pharmacy Quality Alliance developed the “Medication Access Framework for Quality Measurement” to address the social determinants of health that hinder patient medication access and contribute to poor health outcomes.
Panelists share final thoughts and advice regarding the critical role pharmacy has played and continues to play in public health initiatives.
Metformin has been the drug of choice for the treatment of diabetes since the 1950s, but new changes suggest the consideration of SGLT-2 inhibitors or GLT-1 agonists.
The adjuvant therapy has demonstrated varied efficacy for patients.
The cost of defending license matters and malpractice claim costs have increased over a 5-year period (2017-2022).
Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.
Diversity, equity, and inclusion programs in pharmacy can lead to better health outcomes for patients.
In recent years, telestroke services have transformed stroke care delivery, especially in rural or underserved areas.
By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
Implementing these standards can be logistically challenging.
Artificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
They can continue to put pressure on companies and regulatory bodies to make the system work for them and not the other way around.
Pharmacists must understand the value of monitoring changes in quality of life and headache frequency to help facilitate the decision to continue, discontinue, or restart migraine prophylaxis.
An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.
With many people remaining to be vaccinated against COVID-19 and everyone 6 months and older needing an annual influenza vaccine for the 2021-2022 season, many pharmacies are turning to pharmacy technicians to assist in the process.
The pharmaceutical industry is facing a critical talent shortage caused by fewer students entering the field, burnout and a lack of stability. We offer ways to combat the shortage.
Precision medicine in pharmacy has the potential to revolutionize patient care by optimizing drug selection, dosing, and monitoring.
Initiating such discussions can be hard, but they can greatly affect health outcomes.
In November 2023, the FDA announced an investigation of CAR T-cell therapy based on several reported secondary T-cell malignancies.
Pharmacists play a vital role in therapy selection.
Recent studies suggest limited benefit post-myocardial infarction for patients with preserved heart function, prompting potential updates to treatment guidelines and reconsideration of long-term use.
An overview of antidepressant medications and their indications to inform health care professionals of their wide use and to better understand which antidepressant to recommend based on patient-specific characteristics.
This step-by-step primer describes the implementation process for β-lactam TDM.
This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.
The entire pharmacy profession and all those interested in medication safety need to coalesce around the need for systemic change in community pharmacy workplace environments.
Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.
The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
An overview of acid reflux and gastroesophageal reflux disease, over-the-counter options, long-term effects of proton pump inhibitors, lifestyle recommendations, and when to refer patients.